Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02823145 Org: User:
Start: 06/08/16 End: 01/27/23 Due: 01/27/24

A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol

Phase: N/A Priority: Normal
NCT ID: NCT03467113 Org: User:
Start: 01/19/18 End: 06/24/20 Due: 06/24/21

A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03299842 Org: User:
Start: 07/12/17 End: 07/05/18 Due: 07/05/19

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02926898 Org: User:
Start: 01/27/17 End: 06/05/18 Due: 06/05/19

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02682927 Org: User:
Start: 01/15/16 End: 07/29/20 Due: 07/29/21

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03355209 Org: User:
Start: 11/27/17 End: 05/23/24 Due: 05/23/25